$8.37
-0.21-2.45%
Last update: Nov 10, 7:54 PM
SELLAS Life Sciences Group Inc
SLSNASDAQ
SELLAS Life Sciences rose 468.2% from $1.51 to $8.58, ahead of the S&P 500's +9.8%. Its worst day was Jan 6 (−18.0%), and its low came Nov 17 at $1.41.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.06 beat the $-0.08 estimate on $0.00 revenue.
−2.0% · S&P 500 −1.7%
SELLAS Life Sciences shares rose 18.8%, while the S&P 500 rose 0.2%.
Story events cover the past 12 months · Times ET
+18.8% · S&P 500 +0.2%
EPS of $-0.05 beat the $-0.06 estimate on $0.00 revenue.
−8.5% · S&P 500 −1.4%
EPS of $-0.05 beat the $-0.06 estimate on $0.00 revenue.
+25.1%, the year's best day · S&P 500 +0.6%
SELLAS Life Sciences shares rose 24.7%, while the S&P 500 rose 1.6%.
+24.7%, on 33M shares, the year's heaviest volume · S&P 500 +1.6%
EPS of $-0.05 missed the $-0.04 estimate on $0.00 revenue.
+6.5% · S&P 500 +0.3%
SELLAS Life Sciences closed at its highest level of the year, 923.8% above where the year started.
+15.4% · S&P 500 +0.4%
Where it ended: a close of $8.58 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.05).
Nothing in the past 12 months.
All SLS dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SLS and SPY from Benzinga historical bars. Not investment advice.
